Finance

Lists
Why is 300497 up 4.50%?
Dive Deeper
300497:SHE
Jiangxi Fushine Pharmaceutical Co Ltd
CNÂĄ13.71
+4.50%
(+0.59) 1D
Nov 4, 3:04:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300497...
Open
CNÂĄ13.08
High
CNÂĄ13.77
Low
CNÂĄ12.90
Mkt. cap
7.07B
Avg. vol.
37.22M
Volume
29.66M
Dividend
0.36%
Quarterly dividend
CNÂĄ0.01
Ex-dividend date
Aug 24, 2026
P/E ratio
18.01
52-wk high
CNÂĄ24.18
52-wk low
CNÂĄ10.53
EPS
CNÂĄ0.76
Shares outstanding
538.65M
No. of employees
2K
Open
CNÂĄ13.08
High
CNÂĄ13.77
Low
CNÂĄ12.90
Mkt. cap
7.07B
Avg. vol.
37.22M
Volume
29.66M
Dividend
0.36%
Quarterly dividend
CNÂĄ0.01
Ex-dividend date
Aug 24, 2026
P/E ratio
18.01
52-wk high
CNÂĄ24.18
52-wk low
CNÂĄ10.53
EPS
CNÂĄ0.76
Shares outstanding
538.65M
No. of employees
2K
News stories
From web sources and news partners
About Jiangxi Fushine Pharmaceutical Co Ltd
CEO-
Employees1.66K
FoundedMar 20, 2002
Headquarters-
SectorPharmaceutical industry
Industry-
Websitefushine.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
415.64M
357.76M
530.49M
661.89M
Cost of goods sold
318.51M
220.70M
331.53M
310.87M
Cost of revenue
318.51M
220.70M
331.53M
310.87M
Research and development expenses
15.40M
12.98M
22.08M
24.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49.14M
36.10M
42.99M
45.25M
Operating expense
107.93M
58.20M
71.21M
89.27M
Total operating expenses
426.44M
278.89M
402.75M
400.14M
Operating income
-10.80M
78.87M
127.74M
261.75M
Other non operating income
5.39M
-5.89M
1.71M
-12.95M
EBT including unusual items
-3.56M
59.20M
111.14M
269.40M
EBT excluding unusual items
-24.11M
61.52M
110.06M
279.93M
Income tax expense
-8.28M
-263.12K
-1.51M
45.63M
Effective tax rate
232.34%
-0.44%
-1.36%
16.94%
Other operating expenses
34.37M
4.09M
950.12K
8.70M
Net income
7.73M
61.20M
115.75M
225.95M
Net profit margin
1.86%
17.11%
21.82%
34.14%
Earnings per share
-
-
-
-
Interest and investment income
997.56K
764.06K
1.18M
33.44M
Interest expense
-16.38M
-12.22M
-11.11M
-11.77M
Net interest expenses
-15.38M
-11.46M
-9.93M
21.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
35.99M
125.66M
177.38M
308.54M
Gain or loss from assets sale
377.06K
-
-2.64K
2.64K
Upcoming events
AI content may include mistakes. Learn more
Google apps